TALENT® OCCLUDER OCL12USRecalls & reported problems
Medtronic, Inc. · STENT GRAFT OCL12US 12MM OCCLUDER · Class 3 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 1
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00613994573148), received between May 10, 2017 and Jun 26, 2018 — classified as 1 death, 1 injury.
The most frequently reported specific device problem is “Difficult to Remove” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Difficult to Remove1
- Leak/Splash1
- Malposition of Device1
Patient problems
- Cardiac Arrest1
- Death1
- Injury1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
DeathJun 26, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AN ENDURANT STENT GRAFT SYSTEM AND TALENT OCCLUDER PLUGS WERE IMPLANTED IN A PATIENT FOR THE EMERGENCY ENDOVASCULAR TREATMENT OF A RUPTURED ABDOMINAL AORTIC ANEURYSM. IT WAS REPORTED THAT THE PATIENT PRESENTED WITH A RUPTURED ABDOMINAL AORTIC ANEURYSM AND WAS GREY IN COLOR UPON ARRIVAL. IT WAS REPORTED THAT THE PHYSICIAN CHOSE THE SIZING OF THE DEVICES VIA ANGIOGRAM CHOOSING AN ENDURANT AUI AND A 16X24X93 ENDURANT LIMB. TWO TALENT OCCLUDER PLUGS WERE IMPLANTED ON THE RIGHT SIDE TO OCCLUDE THE ILIAC ARTERY. ONCE THE EVAR PROCEDURE WAS COMPLETED THE PROCEDURE TRANSITIONED TO A FEM-FEM BYPASS. IT WAS REPORTED THAT THE PATIENTS¿ BLOOD PRESSURE WAS LOW DURING THE ENTIRE PROCEDURE AND REMAINED LOW AFTER THE EVAR. THE PHYSICIAN REMARKED THAT THE PATIENTS ABDOMEN FELT LIKE A DRUM AND THE DECISION WAS MADE TO OPEN UP THE ABDOMEN TO EXPLORE FOR INTERNAL BLEEDING, NONE WAS FOUND YET THE PATIENTS¿ BLOOD PRESSURE KEPT DROPPING. RESUSCITATION WAS ATTEMPTED FOR 20 MINUTES BUT THE PATIENT EXPIRED. AS PER THE PHYSICIAN, THE CAUSE OF THE EVENT WAS DUE TO MULTIPLE COMORBIDITIES; CHRONIC RENAL FAILURE AND SHOCK. THE DEFINITIVE CAUSE OF THE RUPTURE COULD NOT BE DETERMINED. NO ADDITIONAL CLINICAL SEQUEL
Patient problems: Cardiac Arrest; Death
MAUDE report 7637046 ↗InjuryMay 10, 2017Leak/Splash; Difficult to Remove; Malposition of Device; Leak/Splash; Difficult to Remove; Malposition of Device
AN ENDURANT II AUI STENT GRAFT SYSTEM AND A TALENT OCCLUDER WERE IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 5.7 CM IN DIAMETER ABDOMINAL AORTIC ANEURYSM. THE VESSEL MORPHOLOGY WAS REPORTED AS VERY TIGHT AND CALCIFIED AORTIC BIFURCATION. THE RIGHT ILIAC ARTERY MEASURED BETWEEN 6 MM AND 7 MM IN DIAMETER. THE LEFT ILIAC ARTERY MEASURED FROM BETWEEN 4 MM AND 5 MM IN DIAMETER TO BETWEEN 5 MM AND 6 MM IN DIAMETER. THE PROXIMAL AORTIC NECK MEASURED 24 MM IN DIAMETER. THERE WAS SEVERE LEFT ILIAC CALCIFICATION. THERE WAS MODERATE TO SEVERE RIGHT ILIAC CALCIFICATION. THERE WAS MILD CALCIFICATION AT THE PROXIMAL AORTIC NECK. THE PATIENT HAD A WIDE AND CONICAL PROXIMAL AORTIC NECK. THE LEFT RENAL ARTERY WAS THE LOWEST RENAL ARTERY AND THE RIGHT RENAL ARTERY WAS ATROPHIC. IT WAS REPORTED THAT ENDURANT AUI WAS ADVANCED UP TO THE LEFT RENAL STENT. THE ENDURANT AUI WAS INITIALLY DEPLOYED AND IMPLANTED AT THE INTENDED LANDING ZONE. HOWEVER, WHEN THE DELIVERY SYSTEM WAS BEING REMOVED, THERE WERE DIFFICULTIES REMOVING THE DELIVERY SYSTEM. THE GRAFT COVER WAS BELOW THE AREA OF CALCIFIED/TIGHT AORTA AND THE SPINDLE AND TAPER TIP COULD NOT BE RETRACTED BACK TO THE GRAFT COVER. THE PHYSIC
Patient problems: Injury
MAUDE report 6557392 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page